Antibodies raised against purified β-adrenergic receptors specifically bind β-adrenergic ligands

  1. Marc G. Caron,,*,
  2. Yogambal Srinivasan,§,
  3. Ralph Snyderman,,ǁ, and
  4. Robert J. Lefkowitz,,§
  1. §Howard Hughes Medical Institute Laboratory, Duke University Medical Center, Durham, North Carolina 27710
  2. Department of Medicine, Duke University Medical Center, Durham, North Carolina 27710
  3. Department of Biochemistry, Duke University Medical Center, Durham, North Carolina 27710
  4. Department of Microbiology, Duke University Medical Center, Durham, North Carolina 27710
  5. ǁDepartment of Immunology, Duke University Medical Center, Durham, North Carolina 27710

Abstract

Antibodies raised against purified β-adrenergic receptors themselves specifically bind β-adrenergic ligands. Digitonin-solubilized frog (Rana pipiens) erythrocyte β-adrenergic receptors, purified 100- to 200-fold by adsorption to an alprenolol-agarose affinity support and specifically eluted from the affinity resin by 1-100 mM (±)-isoproterenol, were used to immunize six rabbits. All immune sera, in contrast to preimmune sera, bound the β-adrenergic antagonist [3H]Dihydroalprenolol binding activity was due to immunoglobulins. By competition studies, antibody [3H]dihydroalprenolol binding was found to display a specificity and stereoselectivity resembling that of the β-adrenergic receptor, [i.e., (-)-isoproterenol > (-)-epinephrine > (-)-norepinephrine; alprenolol ≈ propranolol ≫ phentolamine = aloperidol; and (-) isomers of both agonists and antagonists 10-100 times more potent than (+) isomers]. A portion of the [3H]dihydroalprenolol binding antibodies could be specifically adsorbed onto purified frog erythrocyte membranes, whereas Xenopus and human erythrocyte membranes, both of which are almost devoid of β-adrenergic receptors, were ineffective in adsorbing [3H]dihydroalprenolol binding antibodies. We suggest that the likely immunogen was a β-adrenergic receptor-isoproterenol complex and that immunization with drugs noncovalently bound to their receptors might be a means of raising antibodies to biologically active otherwise nonimmunogenic small molecules. Such antibodies, whose specificity mimics that of a receptor, should also provide useful models for the study of the structure of the receptor binding sites.

Footnotes

  • * To whom correspondence and reprint requests should be addressed at: Box 3287, Duke University Medical Center, Durham, NC 27710.

« Previous | Next Article »Table of Contents